Search

Your search keyword '"Dellon, Evan S."' showing total 2,617 results
Start Over Author "Dellon, Evan S."
2,617 results on '"Dellon, Evan S."'

4. Harnessing Digital Pathology And Causal Learning To Improve Eosinophilic Esophagitis Dietary Treatment Assignment

Author

Aknin, Eliel, Larey, Ariel, Caldwell, Julie M., Collins, Margaret H., Abonia, Juan P., Aceves, Seema S., Arva, Nicoleta C., Chehade, Mirna, Dellon, Evan S., Gonsalves, Nirmala, Gupta, Sandeep K., Leung, John, Peterson, Kathryn A., Shoda, Tetsuo, Spergel, Jonathan M., Rothenberg, Marc E., and Savir, Yonatan

Subjects
Computer Science - Machine Learning
Abstract

Eosinophilic esophagitis (EoE) is a chronic, food antigen-driven, allergic inflammatory condition of the esophagus associated with elevated esophageal eosinophils. EoE is a top cause of chronic dysphagia after GERD. Diagnosis of EoE relies on counting eosinophils in histological slides, a manual and time-consuming task that limits the ability to extract complex patient-dependent features. The treatment of EoE includes medication and food elimination. A personalized food elimination plan is crucial for engagement and efficiency, but previous attempts failed to produce significant results. In this work, on the one hand, we utilize AI for inferring histological features from the entire biopsy slide, features that cannot be extracted manually. On the other hand, we develop causal learning models that can process this wealth of data. We applied our approach to the 'Six-Food vs. One-Food Eosinophilic Esophagitis Diet Study', where 112 symptomatic adults aged 18-60 years with active EoE were assigned to either a six-food elimination diet (6FED) or a one-food elimination diet (1FED) for six weeks. Our results show that the average treatment effect (ATE) of the 6FED treatment compared with the 1FED treatment is not significant, that is, neither diet was superior to the other. We examined several causal models and show that the best treatment strategy was obtained using T-learner with two XGBoost modules. While 1FED only and 6FED only provide improvement for 35%-38% of the patients, which is not significantly different from a random treatment assignment, our causal model yields a significantly better improvement rate of 58.4%. This study illustrates the significance of AI in enhancing treatment planning by analyzing molecular features' distribution in histological slides through causal learning. Our approach can be harnessed for other conditions that rely on histology for diagnosis and treatment., Comment: 11 pages, 5 figures

Published
2023

5. Quantification of Mucosal Mast Cells in the Gastrointestinal Tract: A Primer for Practicing Pathologists

Author

Genta, Robert M., Turner, Kevin O., Collins, Margaret H., Wechsler, Joshua B., Arva, Nicoleta C., Pletneva, Maria A., Dellon, Evan S., and Walker, Marjorie M.

Subjects
Gastrointestinal system, Gastrointestinal diseases, Health
Abstract

* Context.--Mast cells are essential components of the immune system and play crucial pathogenetic roles in several digestive diseases, including mastocytic enterocolitis and eosinophilic gastrointestinal disorders. Pathologists have rarely been asked to evaluate the distribution and density of mast cells in gastrointestinal (GI) biopsy specimens. However, such requests are becoming more common because of an increasing awareness of the role of mast cells in functional GI disease and in both esophageal and nonesophageal eosinophilic gastrointestinal disorders. Objective.--To provide pathologists with tools to incorporate the assessment of mast cells in the evaluation of esophageal, gastric, and intestinal specimens by developing a systematic approach to their evaluation, counting, and reporting. Design.--This study consisted of a review of the literature followed by multiple consensus sessions to decide where to count mast cells and what a countable mast cell is. Results.--We reviewed 135 papers addressing the content of mast cells in the digestive tract, selected 21 that detailed how cells were counted (microscope lens, area of high-power fields, locations evaluated, type of cells considered as countable), and summarized their data in a table. Then, drawing from both the acceptable literature and our own extensive experience, we reached a tentative consensus on: (1) the normal numbers in the different segments of the GI tract; (2) the morphology of countable mast cells; and (3) the locations and strategies for counting them. Conclusions.--The result is a set of suggestions for reporting mast cell counts, their distribution, and their location in a way clinicians can understand and use for management decisions. (Arch Pathol Lab Med. 2024; 148:e25-e35; doi: 10.5858/arpa.2023-0070-OA), The discovery of mast cells and the gradual understanding of their role in the immune system have been described in fascinating detail by Blank et al. (1) First reported by [...]

Published
2024
Full Text
View/download PDF

9. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis

Author

Sato, Hiroki, Dellon, Evan S., Aceves, Seema S., Arva, Nicoleta C., Chehade, Mirna, Collins, Margaret H., Davis, Carla M., Falk, Gary W., Furuta, Glenn T., Gonsalves, Nirmala P., Gupta, Sandeep K., Hirano, Ikuo, Hiremath, Girish, Katzka, David A., Khoury, Paneez, Leung, John, Menard-Katcher, Paul, Pesek, Robbie, Peterson, Kathryn A., Pletneva, Maria A., Spergel, Jonathan M., Wechsler, Joshua B., Yang, Guang-Yu, Rothenberg, Marc E., and Shoda, Tetsuo

Published
2024
Full Text
View/download PDF

10. Do General Pathologists Assess Gastric and Duodenal Eosinophilia? A Community-Based Study

Author

Saad, A. Joe, Genta, Robert M., Turner, Kevin O., Kamboj, Amol P., Dellon, Evan S., and Chehade, Mirna

Subjects
Gastrointestinal system -- Analysis, Gastrointestinal diseases -- Analysis, Eosinophilia -- Analysis, Health
Abstract

* Context.--Eosinophilic diseases of the gastrointestinal tract (EGIDs), eosinophilic gastritis (EoG), and eosinophilic duodenitis (EoD) are rarely suspected clinically and infrequently detected by pathologists. Objective.--To determine whether histories of allergic or eosinophilic disorders and requests to rule out EoG and EoD affect pathologists' awareness of eosinophils in gastrointestinal biopsies. Design.--Thirty-one community-based pathologists were given 16 sets of biopsies from gastric and duodenal mucosa with elevated eosinophils, Helicobacter pylori gastritis, atrophic gastritis, normal stomach and duodenum, lymphocytosis, and celiac disease. Participants were assigned to 3 groups: group A did not receive histories of allergic or eosinophilic conditions; group B received similar histories plus a clue of possible allergic or eosinophilic conditions; and group C received the same histories as B and was asked to rule out EoG/EoD. A list of gastric and duodenal diagnoses and a space for comments were provided. Results were analyzed descriptively. Results.--Pathologists correctly diagnosed most non-eosinophilic gastrointestinal disorders, indicating competence in gastrointestinal pathology. With respect to EoG and EoD, pathologists in group C performed significantly better that those in groups A and B. The combined odds ratio with 95% CI was 12.34 (2.87-53.04), P < .001, for A versus C and 4.02 (1.60-10.09), P < .02, for B versus C. Conclusions.--Most pathologists neither reported gastric/duodenal eosinophilia nor diagnosed EoG/EoD, even when provided histories of eosinophilic disorders. Requests to rule out EoG/EoD resulted in only 4 of 11 participants evaluating and counting eosinophils in some cases. Simple evidence-based histopathologic criteria are needed before pathologists can be expected to consider and diagnose EGIDs., The prevalence of nonesophageal eosinophilic gastrointestinal disorders (EGIDs) remains poorly characterized, but is generally believed to be low, (1) and EGIDs are generally considered to be rare diseases. (2) Estimates [...]

Published
2023
Full Text
View/download PDF

12. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time

Author

Greuter, Thomas, Straumann, Alex, Fernandez-Marrero, Yuniel, Germic, Nina, Hosseini, Aref, Chanwangpong, Apinya, Yousefi, Shida, Simon, Dagmar, Collins, Margaret H., Bussmann, Christian, Chehade, Mirna, Dellon, Evan S., Furuta, Glenn T., Gonsalves, Nirmala, Hirano, Ikuo, Moawad, Fouad J., Biedermann, Luc, Safroneeva, Ekaterina, Schoepfer, Alain M., and Simon, Hans-Uwe

Published
2024
Full Text
View/download PDF

15. A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME

Author

Greuter, Thomas, Straumann, Alex, Fernandez-Marrero, Yuniel, Germic, Nina, Hosseini, Aref, Chanwangpong, Apinya, Yousefi, Shida, Simon, Dagmar, Collins, Margaret H., Bussmann, Christian, Chehade, Mirna, Dellon, Evan S., Furuta, Glenn T., Gonsalves, Nirmala, Hirano, Ikuo, Moawad, Fouad J., Biedermann, Luc, Safroneeva, Ekaterina, Schoepfer, Alain M., and Simon, Hans-Uwe

Published
2024
Full Text
View/download PDF

25. Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis

Author

Martin, Lisa J., Zhang, Xue, Chehade, Mirna, Davis, Carla M., Dellon, Evan S., Falk, Gary W., Gupta, Sandeep K., Hirano, Ikuo, Hiremath, Girish S., Katzka, David A., Khoury, Paneez, Leung, John, Menard-Katcher, Paul, Gonsalves, Nirmala, Pesek, Robert D., Spergel, Jonathan M., Wechsler, Joshua B., Kliewer, Kara, Arva, Nicoleta C., Collins, Margaret H., Pletneva, Maria, Yang, Guang-Yu, Furuta, Glenn T., Rothenberg, Marc E., and Aceves, Seema S.

Published
2024
Full Text
View/download PDF

26. Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis

Author

Kim, Seung, Ben-Baruch Morgenstern, Netali, Osonoi, Kasumi, Aceves, Seema S., Arva, Nicoleta C., Chehade, Mirna, Collins, Margaret H., Dellon, Evan S., Falk, Gary W., Furuta, Glenn T., Gonsalves, Nirmala P., Gupta, Sandeep K., Hirano, Ikuo, Hiremath, Girish, Katzka, David A., Khoury, Paneez, Leung, John, Pesek, Robbie, Peterson, Kathryn A., Pletneva, Maria A., Spergel, Jonathan M., Wechsler, Joshua B., Yang, Guang-Yu, Rothenberg, Marc E., and Shoda, Tetsuo

Published
2024
Full Text
View/download PDF

31. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting

Author

Chehade, Mirna, Wright, Benjamin L., Atkins, Dan, Aceves, Seema S., Ackerman, Steven J., Assa’ad, Amal H., Bauer, Maureen, Collins, Margaret H., Commins, Scott P., Davis, Carla M., Dellon, Evan S., Doerfler, Bethan, Gleich, Gerald J., Gupta, Sandeep K., Hill, David A., Jensen, Elizabeth T., Katzka, David, Kliewer, Kara, Kodroff, Ellyn, Kottyan, Leah C., Kyle, Shay, Muir, Amanda B., Pesek, Robert D., Peterson, Kathryn, Shreffler, Wayne G., Spergel, Jonathan M., Strobel, Mary Jo, Wechsler, Joshua, Zimmermann, Nives, Furuta, Glenn T., and Rothenberg, Marc E.

Published
2023
Full Text
View/download PDF

32. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Author

Rothenberg, Marc E, Dellon, Evan S, Collins, Margaret H, Hirano, Ikuo, Chehade, Mirna, Bredenoord, Albert J, Lucendo, Alfredo J, Spergel, Jonathan M, Sun, Xian, Hamilton, Jennifer D, Mortensen, Eric, Laws, Elizabeth, Maloney, Jennifer, Mannent, Leda P, McCann, Eilish, Liu, Xia, Glotfelty, Lila, and Shabbir, Arsalan

Published
2023
Full Text
View/download PDF

35. Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis

Author

Hiremath, Girish, Sun, Lili, Collins, Margaret H., Bonis, Peter A., Arva, Nicoleta C., Capocelli, Kelley E., Chehade, Mirna, Davis, Carla M., Falk, Gary W., Gonsalves, Nirmala, Gupta, Sandeep K., Hirano, Ikuo, Leung, John, Khoury, Paneez, Mukkada, Vincent A., Martin, Lisa J., Spergel, Jonathan M., Wechsler, Joshua B., Yang, Guang-Yu, Aceves, Seema S., Furuta, Glenn T., Rothenberg, Marc.E., Koyama, Tatsuki, and Dellon, Evan S.

Published
2023
Full Text
View/download PDF

37. Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations

Author

Arnim, Ulrike von, Biedermann, Luc, Aceves, Seema S., Bonis, Peter A., Collins, Margaret H., Dellon, Evan S., Furuta, Glenn T., Gonsalves, Nirmala, Gupta, Sandeep, Hirano, Ikuo, Lucendo, Alfredo J., Miehlke, Stephan, Oliva, Salvatore, Schlag, Christoph, Schoepfer, Alain, Straumann, Alex, Vieth, Michael, and Bredenoord, Albert J.

Published
2023
Full Text
View/download PDF

41. Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis

Author

Aceves, Seema S., Abonia, Pablo, Atkins, Dan, Bonis, Peter A., Chehade, Mirna, Falk, Gary W., Furuta, Glenn T., Gupta, Sandeep K., Kagalwalla, Amir F., Kodroff, Ellyn, Kyle, Scholeigh, Leung, John, Menard-Katcher, Paul, Mir, Sabina, Mukkada, Vincent A., Pesek, Robert, Rothenberg, Marc E., Spergel, Jonathan M., Strobel, Mary Jo, Wechsler, Joshua B., Chang, Joy W., Kliewer, Kara, Haller, Emily, Lynett, Amanda, Doerfler, Bethany, Katzka, David A., Peterson, Kathryn A., Dellon, Evan S., and Gonsalves, Nirmala

Published
2023
Full Text
View/download PDF

43. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial

Author

Kliewer, Kara L, Gonsalves, Nirmala, Dellon, Evan S, Katzka, David A, Abonia, Juan P, Aceves, Seema S, Arva, Nicoleta C, Besse, John A, Bonis, Peter A, Caldwell, Julie M, Capocelli, Kelley E, Chehade, Mirna, Cianferoni, Antonella, Collins, Margaret H, Falk, Gary W, Gupta, Sandeep K, Hirano, Ikuo, Krischer, Jeffrey P, Leung, John, Martin, Lisa J, Menard-Katcher, Paul, Mukkada, Vincent A, Peterson, Kathryn A, Shoda, Tetsuo, Rudman Spergel, Amanda K, Spergel, Jonathan M, Yang, Guang-Yu, Zhang, Xue, Furuta, Glenn T, and Rothenberg, Marc E

Published
2023
Full Text
View/download PDF

44. High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate–Severe Abdominal Symptoms: A Prospective US Multisite Study

Author

Talley, Nicholas J., Peterson, Kathryn A., Genta, Robert M., Chang, Alan T., Dellon, Evan S., Sandborn, William J., Lacy, Brian E., Chehade, Mirna, Hirano, Ikuo, Gonsalves, Nirmala, Lembo, Anthony, Schmitt, Colleen M., Rothenberg, Marc E., Jain, Neal, Pletneva, Maria A., Turner, Kevin O., and Youngblood, Bradford A.

Published
2023
Full Text
View/download PDF

45. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters

Author

Rank, Matthew A, Sharaf, Rajiv N, Furuta, Glenn T, Aceves, Seema S, Greenhawt, Matthew, Spergel, Jonathan M, Falck-Ytter, Yngve T, Dellon, Evan S, Institute, AGA, Chachu, Karen A, Day, Lukejohn, Lebwohl, Benjamin, Muniraj, Thiruvengadam, Patel, Amit, Peery, Anne F, Shah, Raj, Singh, Harminder, Singh, Siddharth, Spechler, Stuart J, Sultan, Shahnaz, Su, Grace L, Thrift, Aaron P, Weiss, Jennifer M, Weizman, Adam V, collaborators, Joint Task Force on Allergy-Immunology Practice Parameters, Bernstein, Jonathan A, Dinakar, Chitra, Golden, David BK, Khan, David A, Lieberman, Jay, Oppenheimer, John, Shaker, Marcus, Stukus, David R, Wallace, Dana V, and Wang, Julie

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Food Allergies, Digestive Diseases, Clinical Research, Nutrition, Advisory Committees, Allergens, Allergy and Immunology, Diet, Eosinophilic Esophagitis, Expert Testimony, Glucocorticoids, Humans, Immunotherapy, Interdisciplinary Communication, Practice Guidelines as Topic, Proton Pump Inhibitors, AGA Institute. Electronic address: clinicalpractice@gastro.org, Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com, AGA Institute, Joint Task Force on Allergy-Immunology Practice Parameters collaborators, Immunology, Allergy
Abstract

Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute and the Joint Task Force on Allergy-Immunology Practice Parameters to provide a technical review to be used as the basis for an updated clinical guideline. This technical review was developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Eighteen focused EoE management questions were considered, with 15 answered using the GRADE framework and 3 with a narrative summary. There is moderate certainty in the evidence that topical glucocorticosteroids effectively reduce esophageal eosinophil counts to

Published
2020

46. The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta‐analysis

Author

Muir, Amanda B, Whelan, Kelly A, Dougherty, Michael K, Aaron, Bailey, Navarre, Brianna, Aceves, Seema S, Dellon, Evan S, and Jensen, Elizabeth T

Subjects
Lung, Clinical Research, Prevention, Cancer, Asthma, Aetiology, 2.1 Biological and endogenous factors, Respiratory, Inflammatory and immune system, Skin, Dermatitis, Atopic, Eosinophilic Esophagitis, Humans, Inflammation, Neoplasms, Immunology, Nutrition and Dietetics, Public Health and Health Services, Allergy
Abstract

ObjectiveWhile chronic inflammation is a well-established risk factor for malignancy, studies evaluating the relationship between allergic inflammation and cancer have revealed conflicting results. Here, we aimed to assess the association between allergic inflammation in the lung (asthma), skin (eczema) or oesophagus (eosinophilic oesophagitis; EoE) and cancer at the organ site.DesignWe conducted a systematic review of the literature to identify observational studies (case-control, cohort and cross-sectional) evaluating the association between asthma and lung cancer, eczema and skin cancer, or EoE and oesophageal cancer. Random-effects meta-analysis was performed to define pooled estimates of effects.Data sourcesPubMed, EMBASE and Web of Science.Eligibility criteria for selectionIncluded studies evaluated the incidence of cancer.ResultsThirty-two studies met the inclusion criteria, 27 in the lung, four in the skin and one in the oesophagus. Meta-analysis of the three studies with prospective data collection of asthma diagnosis revealed a positive association with incident lung cancer (OR 1.27, 95% CI 1.09-1.44); however, this result was not consistently supported by the larger dataset of retrospective studies (OR 1.37, 95% CI 0.90-1.83). Overall, studies in the lung displayed significant heterogeneity (I2 98%, P

Published
2020

47. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study

Author

Shoda, Tetsuo, Wen, Ting, Caldwell, Julie M, Collins, Margaret H, Besse, John A, Osswald, Garrett A, Abonia, J Pablo, Arva, Nicoleta C, Atkins, Dan, Capocelli, Kelley E, Dellon, Evan S, Falk, Gary W, Gonsalves, Nirmala, Gupta, Sandeep K, Hirano, Ikuo, Mukkada, Vincent A, Putnam, Philip E, Sheridan, Rachel M, Spergel, Amanda K Rudman, Spergel, Jonathan M, Wechsler, Joshua B, Yang, Guang-Yu, Aceves, Seema S, Furuta, Glenn T, Rothenberg, Marc E, and Researchers, Consortium of Eosinophilic Gastrointestinal Disease

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Digestive Diseases, Clinical Research, Detection, screening and diagnosis, 4.1 Discovery and preclinical testing of markers and technologies, Adolescent, Adult, Biomarkers, Child, Cytokines, Endoscopy, Gastrointestinal, Enteritis, Eosinophilia, Female, Gastritis, Humans, Male, Biomarker, diagnostic panel, eosinophil, eosinophilic gastritis, transcriptome, Consortium of Eosinophilic Gastrointestinal Disease Researchers, Immunology, Allergy
Abstract

BackgroundEosinophilic gastritis (EG) is a clinicopathologic disorder with marked gastric eosinophilia and clinical symptoms. There is an unmet need among patients with EG for more precise diagnostic tools.ObjectiveWe aimed to develop tissue- and blood-based diagnostic platforms for EG.MethodsPatients with EG and control subjects without EG were enrolled across 9 Consortium of Eosinophilic Gastrointestinal Disease Researchers-associated sites. An EG Diagnostic Panel (EGDP; gastric transcript subset) and EG blood biomarker panel (protein multiplex array) were analyzed. EGDP18 scores were derived from the expression of 18 highly dysregulated genes, and blood EG scores were derived from dysregulated cytokine/chemokine levels.ResultsGastric biopsy specimens and blood samples from 185 subjects (patients with EG, n = 74; control subjects without EG, n = 111) were analyzed. The EGDP (1) identified patients with active EG (P < .0001, area under the curve ≥ 0.95), (2) effectively monitored disease activity in longitudinal samples (P = .0078), (3) highly correlated in same-patient samples (antrum vs body, r = 0.85, P < .0001), and (4) inversely correlated with gastric peak eosinophil levels (r = -0.83, P < .0001), periglandular circumferential collars (r = -0.73, P < .0001), and endoscopic nodularity (r = -0.45, P < .0001). For blood-based platforms, eotaxin-3, thymus and activation-regulated chemokine, IL-5, and thymic stromal lymphopoietin levels were significantly increased. Blood EG scores (1) distinguished patients with EG from control subjects without EG (P < .0001, area under the curve ≥ 0.91), (2) correlated with gastric eosinophil levels (plasma: r = 0.72, P = .0002; serum: r = 0.54, P = .0015), and (3) inversely correlated with EGDP18 scores (plasma: r = -0.64, P = .0015; serum: r = -0.46, P = .0084). Plasma eotaxin-3 levels strongly associated with gastric CCL26 expression (r = 0.81, P < .0001).ConclusionWe developed tissue- and blood-based platforms for assessment of EG and uncovered robust associations between specific gastric molecular profiles and histologic and endoscopic features, providing insight and clinical readiness tools for this emerging rare disease.

Published
2020

50. Performance of an Artificial Intelligence Model for Recognition and Quantitation of Histologic Features of Eosinophilic Esophagitis on Biopsy Samples

Author

Archila, Luisa Ricaurte, Smith, Lindsey, Sihvo, Hanna-Kaisa, Koponen, Ville, Jenkins, Sarah M., O’Sullivan, Donnchadh M., Cardenas Fernandez, Maria Camila, Wang, Yaohong, Sivasubramaniam, Priyadharshini, Patil, Ameya, Hopson, Puanani E., Absah, Imad, Ravi, Karthik, Mounajjed, Taofic, Dellon, Evan S., Bredenoord, Albert J., Pai, Rish, Hartley, Christopher, Graham, Rondell P., and Moreira, Roger K.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results